CLINICAL BENEFITS AND MECHANISMS OF A SUSTAINED RESPONSE TO INTERMITTENT INSULIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH SECONDARY DRUG FAILURE

被引：61
|
作者：
YKIJARVINEN, H
ESKO, N
EERO, H
MARJARIITTA, T
机构：
[1] UNIV HELSINKI,DEPT MED 2,SF-00100 HELSINKI 10,FINLAND
[2] UNIV HELSINKI,DEPT MED 3,SF-00100 HELSINKI 10,FINLAND
来源：
AMERICAN JOURNAL OF MEDICINE | 1988年 / 84卷 / 02期
关键词：
D O I：
10.1016/0002-9343(88)90412-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 192
页数：8
相关论文
共 50 条
  • [41] FAILURE AND EFFICACY OF INSULIN THERAPY IN INSULIN-DEPENDENT (TYPE-I) DIABETIC-PATIENTS
    WALDHAUSL, W
    HOWORKA, K
    DERFLER, K
    BRATUSCHMARRAIN, PR
    HOLLER, C
    ZYMAN, H
    FREYLER, H
    ACTA DIABETOLOGICA LATINA, 1985, 22 (04): : 279 - 294
  • [42] CRUCIAL ROLE OF RESIDUAL INSULIN-SECRETION IN THE EFFICACY OF GLIPIZIDE ADDED TO INSULIN IN THE MANAGEMENT OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH SECONDARY FAILURE TO SULFONYLUREAS
    CASTILLO, M
    SCHEEN, AJ
    PAOLISSO, G
    LEFEBVRE, PJ
    DIABETOLOGIA, 1987, 30 (07) : A506 - A506
  • [43] MULTIPLE INSULIN INJECTION THERAPY USING AN INSULIN PEN - WHO BENEFITS - A CLINICAL 3-YEAR FOLLOW-UP-STUDY OF 100 TYPE-1 AND 51 TYPE-2 DIABETIC-PATIENTS
    ROSENGREN, A
    ADLERBERTH, A
    BRESATER, LE
    EHNBERG, S
    WELIN, L
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1993, 20 (01) : 69 - 74
  • [44] CHOLESTEROL-BIOSYNTHESIS IN NONKETOTIC TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS BEFORE AND DURING INSULIN THERAPY
    ANDERSEN, E
    HELLSTROM, K
    DIABETOLOGIA, 1986, 29 (08) : A513 - A513
  • [45] RENAL REPLACEMENT THERAPY IN TYPE-2 DIABETIC-PATIENTS - 10 YEARS EXPERIENCE
    HIRSCHL, MM
    HEINZ, G
    SUNDERPLASSMANN, G
    DERFLER, K
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (06) : 564 - 568
  • [46] ENERGY-EXPENDITURE IN TYPE-2 DIABETIC-PATIENTS ON METFORMIN AND SULFONYLUREA THERAPY
    CHONG, PKK
    JUNG, RT
    RENNIE, MJ
    SCRIMGEOUR, CM
    DIABETIC MEDICINE, 1995, 12 (05) : 401 - 408
  • [47] RETINOPATHY IN NEWLY PRESENTING NON-INSULIN-DEPENDENT (TYPE-2) DIABETIC-PATIENTS
    OWENS, DR
    VOLUND, A
    JONES, D
    SHANNON, AG
    JONES, IR
    BIRTWELL, AJ
    LUZIO, S
    WILLIAMS, S
    DOLBEN, J
    CREAGH, FN
    PETERS, JR
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1988, 9 (02): : 59 - 65
  • [48] DIET AND COMPLICATIONS IN MEXICAN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    PAISEY, R
    ARREDONDO, G
    VILLALOBOS, A
    GUBVARA, L
    LOZANO, O
    DIABETOLOGIA, 1982, 23 (05) : 472 - 472
  • [49] EVEN REGULAR HUMAN INSULIN THERAPY IS MORE IMMUNOGENIC IN INSULIN-NAIVE TYPE-1 VS TYPE-2 DIABETIC-PATIENTS
    FINEBERG, NS
    FINEBERG, SE
    MAHLER, RJ
    LINARELLI, LG
    HUFFERD, SC
    GALLOWAY, JA
    CLINICAL RESEARCH, 1989, 37 (04): : A945 - A945
  • [50] TREATMENT OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH DIET ALONE
    WALES, JK
    DIABETOLOGIA, 1982, 23 (03) : 240 - 245
12345